Skip to main content
. 2018 Jun 7;2(3):497–507. doi: 10.1002/rth2.12116

Table 3.

Independent T‐tests for Subscales Measured

Questionnaire Subscale AF patients VTE patients
TTR >75%(n = 187)Mean (SD) TTR <50%(n = 164)Mean (SD) p value TTR >75%(n = 89)Mean (SD) TTR <50%(n = 43)Mean (SD) p value
IPQ‐R Timeline Acute Chronic 24.3 (3.8) 23.1 (4.1) 0.008 25.2 (4.3) 23.3 (5.0) 0.015
Timeline Cyclical 8.9 (3.1) 10.4 (3.2) 0.001 8.0 (3.3) 10.3 (3.7) 0.002
Consequences 16.2 (3.9) 17.6 (4.4) 0.003 16.8 (4.1) 18.4 (4.5) 0.037
Personal Control 18.8 (4.4) 19.7 (4.0) 0.089 18.4 (4.8) 19.8 (4.0) 0.141
Treatment Control 16.4 (2.3) 16.9 (2.6) 0.074 17.1 (2.4) 17.1 (3.0) 0.898
Illness Coherence 18.5 (3.9) 18.3 (3.9) 0.446 18.9 (4.0) 17.2 (4.4) 0.027
Emotional Response 14.2 (4.4) 15.3 (4.7) 0.006 14.5 (5.4) 15.8 (5.1) 0.230
Psychological Cause 13.4 (4.1) 13.4 (4.0) 0.533 11.4 (3.9) 13.0 (4.5) 0.067
Risk Factor Cause 17.0 (3.9) 17.8 (4.2) 0.067 15.3 (3.8) 16.5 (5.1) 0.255
Immune Cause 6.4 (1.9) 6.8 (1.7) 0.017 6.0 (2.1) 6.9 (2.5) 0.041
Accidental Cause 4.5 (1.5) 4.6 (1.5) 0.142 5.2 (1.7) 5.6 (1.8) 0.184
BMQ General Harm 19.9 (6.5) 23.5 (8.0) 0.044 8.9 (2.4) 9.7 (2.9) 0.141
General Overuse 11.4 (2.7) 10.1 (2.7) 0.075 11.2 (2.7) 11.8 (3.3) 0.281
Specific Concern 12.0 (3.5) 13.9 (3.7) 0.001 13.0 (3.6) 14.6 (4.4) 0.032
Specific Necessity 17.3 (3.7) 16.5 (3.2) 0.017 18.5 (3.6) 17.8 (3.8) 0.196
ACTS Burdens 19.9 (6.5) 23.5 (8.0) 0.001 23.5 (8.3) 26.3 (9.3) 0.093
Benefits 11.4 (2.7) 10.1 (2.7) 0.001 11.7 (2.9) 11.6 (2.4) 0.721